Header Logo

Connection

Ravinder Wali to Kidney Diseases

This is a "connection" page, showing publications Ravinder Wali has written about Kidney Diseases.
Connection Strength

2.024
  1. Wali RK, Iyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung AK. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials. Circ Heart Fail. 2011 Jan; 4(1):18-26.
    View in: PubMed
    Score: 0.306
  2. Wali RK. Aspirin and the prevention of cardiovascular disease in chronic kidney disease: time to move forward? J Am Coll Cardiol. 2010 Sep 14; 56(12):966-8.
    View in: PubMed
    Score: 0.304
  3. Wali RK, Weir MR. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function? Curr Opin Organ Transplant. 2008 Dec; 13(6):614-21.
    View in: PubMed
    Score: 0.268
  4. Wali RK, Mohanlal V, Ramos E, Blahut S, Drachenberg C, Papadimitriou J, Dinits M, Joshi A, Philosophe B, Foster C, Cangro C, Nogueira J, Cooper M, Bartlett ST, Weir MR. Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction. Am J Transplant. 2007 Jun; 7(6):1572-83.
    View in: PubMed
    Score: 0.242
  5. Wali RK, Henrich WL. Chronic kidney disease: a risk factor for cardiovascular disease. Cardiol Clin. 2005 Aug; 23(3):343-62.
    View in: PubMed
    Score: 0.213
  6. Wali RK, Drachenberg C, Hirsch HH, Papadimitriou J, Nahar A, Mohanlal V, Brisco MA, Bartlett ST, Weir MR, Ramos E. BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression. Transplantation. 2004 Oct 15; 78(7):1069-73.
    View in: PubMed
    Score: 0.202
  7. Ramos E, Vincenti F, Lu WX, Shapiro R, Trofe J, Stratta RJ, Jonsson J, Randhawa PS, Drachenberg CB, Papadimitriou JC, Weir MR, Wali RK. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation. 2004 Jan 15; 77(1):131-3.
    View in: PubMed
    Score: 0.191
  8. Wali RK, Henrich WL. Recent developments in toxic nephropathy. Curr Opin Nephrol Hypertens. 2002 Mar; 11(2):155-63.
    View in: PubMed
    Score: 0.168
  9. Weir MR, Wali RK. Minimizing the risk of chronic allograft nephropathy. Transplantation. 2009 Apr 27; 87(8 Suppl):S14-8.
    View in: PubMed
    Score: 0.069
  10. Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, Nogueira J, Cangro CB, Haririan A, Mendley S, Ramos E. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007 Aug 15; 84(3):323-30.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.